Concepedia

Harold Goldenberg

HG

Statistics

Publications

20

Citations

586

H-Index

15

Active since

1967

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Sweden)

Institute for Medical Research

Bristol-Myers Squibb (Germany)

Harold Goldenberg is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and biochemistry.

Publications per year

1967–1995

20

Publications

20

Effects of Therapeutic Agents on Cyclic AMP Metabolism In Vitro

Ira Weinryb, Mark Chasin, Charles A. Free et al. · Journal of Pharmaceutical Sciences · 1972 · 96 citations

Life Sciences, Biochemistry, Pharmacology +11

DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors

E.C.K. Liu, Anders Hedberg, Harold Goldenberg et al. · Prostaglandins · 1992 · 56 citations

Medicine, Cardiology, Pharmacology +10

Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist

Steven M. Seiler, Marianne Peluso, Inge M. Michel et al. · Biochemical Pharmacology · 1995 · 40 citations

Medicine, Biochemistry, Pharmacology +16

Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs

Don N. Harris, Christopher L. Heran, Harold Goldenberg et al. · European Journal of Pharmacology · 1978 · 39 citations

Medicine, Cardiology, Pharmacology +12

Enzymes, nucleic acids, and lipids in human breast cancer and normal breast tissue.

Russell Hilf, Harold Goldenberg, Inge M. Michel et al. · PubMed · 1970 · 38 citations

Life Sciences, Biochemistry, Oncology +12

1–5 of 20